Problematising menstrual tracking apps: presenting a novel critical scoping review methodology for mapping and interpreting research literature

To showcase a novel, theoretically informed methodology for conducting scoping reviews by operationalising critical theory. And to advance the field of women's digital health by applying this critical scoping review methodology (CSR) to research on menstrual tracking apps (MTAs). 116 articles published in English, between November 2015 and November 2023, focusing on MTAs, and/or user's experiences of MTAs, were thematically analysed through the Foucauldian concept of problematisation and analytics from critical psychology. This method examined what was produced as a problem, and the underpinning discourses, subject positions, paradigms, desired outcomes, and absences within these problem categories. Four problematisations were identified, (1) the problem of data privacy (subproblems: type of data, consent, abortion surveillance); (2) the problem with efficacy (subproblems: evaluating efficacy, accuracy, useability); (3) the problem of regulation (subproblems: self-surveillance, normative femininity, hormonal imperative, cycle regularity imperative, menstrual stigma); and (4) the problem of women (subproblems: health literacy, technology use, medically unknown, hard to design for). MTA researchers would benefit from understanding their field through these problematisations. The CSR offers an important theoretically informed methodology for mapping and interpreting a research literature, which can identify, and expand, possibilities for research thought and practice.This is an Accepted Manuscript of an article published by Taylor & Francis in Psychology and Health on 2025-01-22, available online: https://www.tandfonline.com/10.1080/08870446.2024.2445518. Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing [email protected].